Categories
Health

Once-Weekly Insulin Looks Good in T2D, but Risk Seen in T1D

Source link : https://www.newshealth.biz/health-news/once-weekly-insulin-looks-good-in-t2d-but-risk-seen-in-t1d/

MADRID, Spain — Eli Lilly’s investigational once-weekly basal insulin analog efsitora alfa continues to show noninferiority to once-daily insulin in people with type 2 diabetes. However, in those with type 1 diabetes, there was an increased risk for hypoglycemia. The data come from Lilly’s QWINT global phase 3 clinical trial program for efsitora alfa, which […]

Author : News Health

Publish date : 2024-09-11 11:34:49

Copyright for syndicated content belongs to the linked Source.

.. . . . . . . . . . . . . . . . . . . . . . . . . .... . . * . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . + + + + + + + + + + + + + + + + + + + + - - - - - - - - - - - - - - - - - - - - . . . . .